A detailed history of Berkeley Capital Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 6,574 shares of JNJ stock, worth $1.08 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
6,574
Previous 6,240 5.35%
Holding current value
$1.08 Million
Previous $987,000 2.74%
% of portfolio
0.29%
Previous 0.3%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $48,222 - $52,698
334 Added 5.35%
6,574 $960,000
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $15,522 - $16,274
100 Added 1.63%
6,240 $987,000
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $31,886 - $34,794
-219 Reduced 3.44%
6,140 $962,000
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $1.03 Million - $1.16 Million
-6,636 Reduced 51.07%
6,359 $990,000
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $134,901 - $145,180
874 Added 7.21%
12,995 $2.15 Million
Q1 2023

May 02, 2023

BUY
$151.05 - $180.26 $37,158 - $44,343
246 Added 2.07%
12,121 $1.88 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $65,361 - $73,354
408 Added 3.56%
11,875 $2.1 Million
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $782,934 - $871,210
4,853 Added 73.37%
11,467 $1.87 Million
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $18,332 - $20,275
109 Added 1.68%
6,614 $1.17 Million
Q1 2022

May 05, 2022

BUY
$158.14 - $179.59 $2,688 - $3,053
17 Added 0.26%
6,505 $1.15 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $67,361 - $74,740
432 Added 7.13%
6,488 $1.11 Million
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $44,735 - $49,713
277 Added 4.79%
6,056 $978,000
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $1,754 - $1,881
11 Added 0.19%
5,779 $952,000
Q1 2021

May 04, 2021

SELL
$153.07 - $170.48 $143,885 - $160,251
-940 Reduced 14.01%
5,768 $948,000
Q4 2020

Jan 28, 2021

SELL
$137.11 - $157.38 $90,492 - $103,870
-660 Reduced 8.96%
6,708 $1.06 Million
Q3 2020

Nov 03, 2020

BUY
$140.38 - $153.83 $114,971 - $125,986
819 Added 12.51%
7,368 $1.1 Million
Q2 2020

Jul 30, 2020

SELL
$128.81 - $155.51 $200,299 - $241,818
-1,555 Reduced 19.19%
6,549 $921,000
Q1 2020

Apr 21, 2020

BUY
$111.14 - $153.99 $38,787 - $53,742
349 Added 4.5%
8,104 $1.06 Million
Q4 2019

Jan 24, 2020

BUY
$127.5 - $146.44 $22,695 - $26,066
178 Added 2.35%
7,755 $1.13 Million
Q3 2019

Nov 01, 2019

SELL
$126.95 - $142.14 $124,664 - $139,581
-982 Reduced 11.47%
7,577 $980,000
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $56,919 - $62,600
-434 Reduced 4.83%
8,559 $1.19 Million
Q1 2019

Apr 30, 2019

SELL
$125.72 - $139.79 $150,109 - $166,909
-1,194 Reduced 11.72%
8,993 $1.26 Million
Q4 2018

Jan 28, 2019

SELL
$122.84 - $147.84 $53,189 - $64,014
-433 Reduced 4.08%
10,187 $1.32 Million
Q3 2018

Oct 30, 2018

BUY
$121.58 - $142.88 $316,594 - $372,059
2,604 Added 32.49%
10,620 $1.47 Million
Q2 2018

Aug 07, 2018

BUY
$119.4 - $131.76 $27,820 - $30,700
233 Added 2.99%
8,016 $972,000
Q1 2018

Apr 27, 2018

BUY
$125.1 - $148.14 $398,443 - $471,825
3,185 Added 69.27%
7,783 $997,000
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $19,026 - $20,824
-145 Reduced 3.06%
4,598 $642,000
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $614,076 - $642,107
4,743
4,743 $617,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Berkeley Capital Partners, LLC Portfolio

Follow Berkeley Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley Capital Partners, LLC with notifications on news.